Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system

Biological Psychiatry

Volumn 53, Issue 4, 2003, Pages 352-359

  Ralph Williams, Rebecca J ^a   Paulus, Martin P ^b   Zhuang, Xiaoxi ^c   Hen, Rene ^d   Geyer, Mark A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d Howard Hughes Medical Institute   (United States)

Author keywords

Dopamine transporter; Hyperactivity; Perseveration; Prepulse inhibition; Valproate

Indexed keywords

DOPAMINE TRANSPORTER; TRANQUILIZER; VALPROIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFICACY; FEMALE; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PERSEVERATION; PREPULSE INHIBITION; PRESERVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; ANTIMANIC AGENTS; BEHAVIOR, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERKINESIS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTATION; NERVE TISSUE PROTEINS; PHENOTYPE; RATS; STARTLE REACTION; VALPROIC ACID;

EID: 0037441746     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01489-0     Document Type: Article

References (42)

1. Bosse R., Fumagalli F., Jaber M., Giros B., Gainetdinov R.R., Wetsel W.C., et al. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron. 19:1997;127-138.
2. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle Normal subjects, patient groups, and pharmacological studies . Psychopharmacology (Berl). 156:2001;234-258.
3. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 49:1992;206-215.
4. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD Preliminary results . Biol Psychiatry. 39:1996;33-41.
5. Cook E.H. Jr, Stein M.A., Krasowski M.D., Cox N.J., Olkon D.M., Kieffer J.E., Leventhal B.L. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 56:1995;993-998.
6. Crowe R.R., Vieland V. Chromosome 5 workshop. Psychiatr Genet. 8:1998;73-78.
7. Curzon P., Decker M.W. Effects of phencyclidine (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice. Prog Neuropsychopharmacol Biol Psychiatry. 22:1998;129-146.
8. Diehl D.J., Gershon S. The role of dopamine in mood disorders. Compr Psychiatry. 33:1992;115-120.
9. Dulawa S.C., Geyer M.A. Psychopharmacology of prepulse inhibition in mice. Chin J Physiol. 39:1996;139-146.
10. Dulawa S.C., Hen R., Scearce-Levie K., Geyer M.A. Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice. Psychopharmacology (Berl). 132:1997;125-134.
11. Emilien G., Maloteaux J.M., Geurts M., Hoogenberg K., Cragg S. Dopamine receptors - physiological understanding to therapeutic intervention potential. Pharmacol Ther. 84:1999;133-156.
12. Fujiwara Y., Yamaguchi K., Tanaka Y., Tomita H., Shiro Y., Kashihara K., et al. Polymorphism of dopamine receptors and transporter genes in neuropsychiatric diseases. Eur Neurol. 38:1997;6-10.
13. Gainetdinov R.R., Jones S.R., Fumagalli F., Wightman R.M., Caron M.G. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res Brain Res Rev. 26:1998;148-153.
14. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science. 283:1999;397-401.
15. Geyer M.A., Russo P.V., Masten V.L. Multivariate assessment of locomotor behavior Pharmacological and behavioral analyses . Pharmacol Biochem Behav. 25:1986;277-288.
16. Geyer M.A., Swerdlow N.R. Measurement of the startle response and its use in preclinical measures of prepulse inhibition and habituation. Crawley J.N., Skolnick P. Current Protocols in Neuroscience. Vol 2:1998;8.7.1-8.7.15 John Wiley & Sons, New York.
17. Gill M., Daly G., Heron S., Hawi Z., Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry. 2:1997;311-313.
18. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
19. Graham F.K. Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology. 12:1975;238-248.
20. Hoffman H.S., Ison J.R. Reflex modification in the domain of startle I. Some empirical findings and their implications for how the nervous system processes sensory input . Psychol Rev. 87:1980;175-189.
21. Johannessen C.U. Mechanisms of action of valproate A commentatory . Neurochem Int. 37:2000;103-110.
22. Kelsoe J.R. Recent progress in the search for genes for bipolar disorder. Curr Psychiatry Rep. 1:1999;135-140.
23. Kelsoe J.R., Sadovnick A.D., Kristbjarnarson H., Bergesch P., Mroczkowski-Parker Z., Drennan M., et al. Possible locus for bipolar disorder near the dopamine transporter on chromosome 5. Am J Med Genet. 67:1996;533-540.
24. Lyon M. Animal models for the symptoms of mania. Boulton A.A., Baker G.B., et al. Animal Models in Psychiatry. 1991;197-244 Humana Press, Clifton, NJ.
25. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 94:1988;507-514.
26. Motohashi N. Algorithms for the pharmacotherapy of bipolar disorder. Psychiatry Clin Neurosci. 53:(suppl):1999;S41-44.
27. O'Donnell T., Rotzinger S., Nakashima T.T., Hanstock C.C., Ulrich M., Silverstone P.H. Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain. Brain Res. 880:2000;84-91.
28. Ornitz E.M., Russell A.T., Hanna G.L., Gabikian P., Gehricke J.G., Song D., Guthrie D. Prepulse inhibition of startle and the neurobiology of primary nocturnal enuresis. Biol Psychiatry. 45:1999;1455-1466.
29. Paulus M.P., Dulawa S.C., Ralph R.J., Mark A.G. Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains. Brain Res. 835:1999;27-36.
30. Paulus M.P., Geyer M.A. A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology. 104:1991;6-16.
31. Perry W., Minassian A., Feifel D., Braff D. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry. 50:2001;418-424.
32. Persico A.M., Catalano M. Lack of association between dopamine transporter gene polymorphisms and delusional disorder. Am J Med Genet. 81:1998;163-165.
33. Persico A.M., Macciardi F. Genotypic association between dopamine transporter gene polymorphisms and schizophrenia. Am J Med Genet. 74:1997;53-57.
34. Ralph R.J., Paulus M.P., Fumagalli F., Caron M.G., Geyer M.A. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice Differential effects of D1 and D2 receptor antagonists . J Neurosci. 21:2001;305-313.
35. Ralph R.J., Paulus M.P., Geyer M.A. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. J Pharmacol Exp Ther. 298:2001;148-155.
36. Ralph R.J., Varty G.B., Kelly M.A., Wang Y.M., Caron M.G., Rubinstein M., et al. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci. 19:1999;4627-4633.
37. Tanda G., Pontieri F.E., Frau R., Di Chiara G. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci. 9:1997;2077-2085.
38. Tohen M., Grundy S. Management of acute mania. J Clin Psychiatry. 60:1999;31-34.
39. Wayment H.K., Schenk J.O., Sorg B.A. Characterization of extracellular dopamine clearance in the medial prefrontal cortex Role of monoamine uptake and monoamine oxidase inhibition . J Neurosci. 21:2001;35-44. discussion:35-36.
40. Wenger G.R. The role of control activity levels in the reported strain differences to the behavioral effects of drugs in mice. Pharmacol Biochem Behav. 32:1989;241-247.
41. Yamamoto B.K., Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem. 71:1998;274-280.
42. Zhuang X., Oosting R.S., Jones S.R., Gainetdinov R.R., Miller G.W., Caron M.G., Hen R. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci U S A. 98:2001;1982-1987.